Rare
lephants
Screener
Toggle theme
CASI Pharmaceuticals, Inc.
CASIF
·
Healthcare, Drug Manufacturers - General, China
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
EPS
Compare
←
5Y
10Y
MAX
→
EPS
Chart
Table
EPS
Cyclically Adjusted EPS
Fiscal Year
EPS
Cyclically Adjusted EPS
FY2023
$-2.02
$-3.43
FY2024
$-2.56
$-3.26
FY2025
$-2.59
$-3.14
Download CSV
